Research progress Support The animal experiments have achieved remarkable results: In the obese mouse model, after daily subcutaneous injection of AOD 9604 (250 g/kg) for 8 weeks, the body weight of the mice decreased by 12%, the subcutaneous fat mass decreased by 25%, and the weight of epididymal adipose tissue significantly decreased, confirming its effectiveness in fat reduction
For researchers conducting long-term studies or those with needle aversion, these practical considerations may outweigh the bioavailability difference
The receptor systems are completely different, and tolerance to one does not predict tolerance to the other
However, there are a few rare cases where this treatment is not recommended
Standard reconstitution produces injectable solution
Before you start taking IMAX, talk to your doctor about your medical history, especially if you have peptic ulcer, regional enteritis, or ulcerative colitis